A Self-Selection and Actual Use Trial conducted by PEGUS Research that investigated whether consumers can correctly select and use a long-acting immediate-release and extended-release 600 mg ibuprofen product was published in the July/August 2016 edition of the Journal of the American Pharmacists Association. Sarah Farnsworth, who managed the study at PEGUS, was one of the authors of the publication. The study sponsor was Pfizer Consumer Healthcare.
We are pleased to have another example of prescription-to-over-the-counter switch research published in the literature, and hope that it can help contribute to the overall body of knowledge regarding critical consumer selection and use behavior dynamics. For additional information, please see the abstract here.
